Channels - PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer :: FRELIP Discovery

Similar Items: PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

Quick Look
Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
Quick Look
Modernizing disease assessment in prostate cancer trials: the Prostate Cancer Working Group 4 framework
Quick Look
Long Non-Coding RNA PVT1 Promotes Doxorubicin Resistance by Inhibiting Ferroptosis in Breast Cancer
Quick Look
PET-MR Examination in Diagnosing Bone Metastases in Prostate Cancer
Quick Look
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Quick Look
Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
Quick Look
PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model
Quick Look
Exploring Genetic Contributions to Prostate Cancer Risk in an Asian Population‐Based Study
Quick Look
Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer
Quick Look
Immune Cell Infiltration and Causal Relationships with Prostate Cancer: A Transcriptomic and Mendelian Randomization Study
Quick Look
Integrative Transcriptomic Signature of tRNA‐Derived Fragment Targets and Lactylation‐Related Genes for Prostate Cancer Diagnosis
Quick Look
Clinicians’ Perspectives on the Impact of Different Attributes of Androgen Receptor Pathway Inhibitors on Prostate Cancer Treatment Preferences and Compliance in Mexico
Quick Look
Induced Electric Fields Inhibit Breast Cancer Growth and Metastasis and Modulate the Immune Tumor Microenvironment
Quick Look
IRF1 Inhibits the Proliferation and Metastasis of Colorectal Cancer by Suppressing the RAS-RAC1 Pathway [Retraction]
Quick Look
Patient-Reported Outcomes on Quality of Life and Psychological Distress After Focal High-Intensity Focused Ultrasound for Prostate Cancer: Prospective Multicenter Study
Quick Look
Inhibition of the Metalloproteinase ADAMTS5 Suppresses Colorectal Cancer Metastasis via the PEDF/Wnt/β‐Catenin Pathway
Quick Look
Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer
Quick Look
Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation
Quick Look
miR-214-3p Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Endometrial Cancer Cells by Targeting TWIST1 [Retraction]
Quick Look
ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer
Quick Look
miR-495 Inhibits Proliferation, Migration, and Invasion and Induces Apoptosis via Inhibiting PBX3 in Melanoma Cells [Retraction]
Quick Look
Mechanisms and Emerging Strategies to Overcome Immunotherapy Resistance in Cold Tumours of Colorectal Cancer
Quick Look
MiR-153-3p Suppresses Cell Proliferation, Invasion and Glycolysis of Thyroid Cancer Through Inhibiting E3F3 Expression [Retraction]
Quick Look
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin